Yarden Drutin Wohl

Mrs. Yarden Drutin Wohl

Barzilai Medical Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DSDoron Sudarsky
Doron Sudarsky
YWYarden Drutin Wohl
Yarden Drutin Wohl
FKFabio Kusniec
Fabio Kusniec
LGLiza Grosman-Rimon
Liza Grosman-Rimon
ALAlla Lubovich
Alla Lubovich
IMIbrahim Marai
Ibrahim Marai
The effect of contrast media (CM), delivered prior to- and during transcatheter aortic valve implantation (TAVI), on kidney function, following the procedure, is debatable. Consequently, the performance of CM-based, acute kidney injury (AKI) risk prediction models is also questionable. We retrospectively studied 210 patients that underwent TAVI. We recorded the dose of CM used prior and during TAVI, calculated the results of different AKI risk assessment models containing a CM module, and tested their association with AKI after the procedure. AKI was diagnosed in 38 patients (18.1%). The baseline estimated glomerular filtration rate (eGFR) was lower in the AKI+ group compared to AKI− group (51 ± 19.3 versus 64.5 ± 19 mL/min/1.73 mr2, respectively). While the dose of CM delivered prior to TAVI, during TAVI or the cumulative amount of both did not differ between the groups, the results of all tested risk models were higher in AKI+ patients. However, by multivariable analysis, only eGFR had a consistent independent association with AKI. We suggest that the dose of CM delivered prior or during TAVI is not associated with AKI and that the predictive power of CM based AKI risk models is, in all probability, limited to eGFR alone.

Verified
Journal Article
Open access
PDF file
BDBatya Davidovici
Batya Davidovici
YWYarden Drutin Wohl
Yarden Drutin Wohl
ATAmir Ben Tov
Amir Ben Tov
DMDaniel Mimouni
Daniel Mimouni
YWYonit Wohl
Yonit Wohl
Background: Alopecia areata (AA) is a chronic autoimmune disorder characterized by non-scarring hair loss and commonly coexists with other autoimmune diseases, suggesting systemic immune dysregulation. An association between AA and iron deficiency anemia (IDA) has been proposed, though prior studies have yielded conflicting results. Objective: Our aim was to examine the association between AA and IDA in a large, population-based cohort. Methods: We conducted a retrospective case–control study using data from a health maintenance organization (HMO) serving approximately 2.35 million individuals. We included 33,401 AA patients diagnosed between 2005 and 2019, matched 1:2 by age and sex with 66,802 controls without AA. Diagnoses of AA and IDA were confirmed through clinical coding by board-certified dermatologists and primary care physicians. Statistical analyses employed Kruskal–Wallis, Pearson’s χ2, and Fisher’s exact tests. Results: IDA prevalence was significantly higher in AA patients than in controls (15% vs. 10%; OR 1.61, 95% CI: 1.55–1.67; p < 0.01). IDA preceded AA in 40% of cases, followed AA in 58%, and occurred concurrently in 2%. Limitations: The retrospective design limits causal inference. Conclusion: This study reinforces an association between AA and IDA, highlighting the need to assess and manage IDA as a potential treatable comorbidity in AA patients.